Simulated Fluctuations in Plasma Drug Concentrations for Patients Receiving Oxcarbazepine or Carbamazepine Extended-Release Capsules

Author： Ahmad Alaa

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.10, 2005-01, pp. : 669-673

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended-Release Carbamazepine Capsules: In Bipolar I Disorder

By Tracy Swainston Harrison Keating Gillian M.

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 709-716

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules in Bipolar I Disorder: Profile Report

By Tracy Swainston Harrison Keating Gillian M.

American Journal of Drug Delivery, Vol. 4, Iss. 1, 2006-01 ,pp. : 51-55

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules: A Viewpoint by Richard H. Weisler

By Weisler Richard H.

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 717-718

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules as Monotherapy in Bipolar Disorder: Pooled Results from Two Randomised, Double-Blind, Placebo-Controlled Trials

By Weisler Richard H. Hirschfeld Robert

CNS Drugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs

By Sommerville K.W.

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite